Contents
Current Cancer Drug Targets, Volume 12 - Number 7
Editorial
Targeted Therapy of Multiple Myeloma: The Changing Paradigm at the Beginning of the New Millennium
, 12(7): 743 - 756Fortunato Morabito, Anna Grazia Recchia, Carla Mazzone and Massimo Gentile
DOI: 10.2174/156800912802429373
Molecular Targets for the Treatment of Multiple Myeloma
, 12(7): 757 - 767Marco Rossi, Maria Teresa Di Martino, Eugenio Morelli, Marzia Leotta, Antonietta Rizzo, Anna Grimaldi, Gabriella Misso, Pierfrancesco Tassone and Michele Caraglia
DOI: 10.2174/156800912802429300
Antiangiogenic Therapeutic Approaches in Multiple Myeloma
, 12(7): 768 - 775Domenico Ribatti, Giuseppe Mangialardi and Angelo Vacca
DOI: 10.2174/156800912802429346
Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma
, 12(7): 776 - 796Paola Neri and Nizar J. Bahlis
DOI: 10.2174/156800912802429337
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
, 12(7): 814 - 822P. Tassone, P. Neri, R. Burger, M. T. Di Martino, E. Leone, N. Amodio, M. Caraglia and P. Tagliaferri
DOI: 10.2174/156800912802429292
MicroRNAs in the Pathobiology of Multiple Myeloma
, 12(7): 823 - 837Marta Lionetti, Luca Agnelli, Luigia Lombardi, Pierfrancesco Tassone and Antonino Neri
DOI: 10.2174/156800912802429274
Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
, 12(7): 838 - 846P. Tagliaferri, M. Rossi, M. T. Di Martino, N. Amodio, E. Leone, A. Gulla, A. Neri and P. Tassone
DOI: 10.2174/156800912802429355
Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells
, 12(7): 847 - 856K. Koike, Y. Ueda, H. Hase, K. Kitae, Y. Fusamae, S. Masai, T. Inagaki, Y. Saigo, S. Hirasawa, K. Nakajima, I. Ohshio, Y. Makino, N. Konishi, H. Yamamoto and K. Tsujikawa
DOI: 10.2174/156800912802429283
A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
, 12(7): 857 - 872Z. Mihaly, Z. Sztupinszki, P. Surowiak and B. Gyorffy
DOI: 10.2174/156800912802429265
A Molecular Signature for Oncogenic BRAF in Human Colon Cancer Cells is Revealed by Microarray Analysis
, 12(7): 873 - 898T. Joyce, E. Oikonomou, V. Kosmidou, E. Makrodouli, I. Bantounas, S. Avlonitis, G. Zografos and A. Pintzas
DOI: 10.2174/156800912802429364
Webmaster Contact: info@benthamscience.net